Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers
Sheila Lumley, Jia Wei, Denise O’Donnell, et al.
Clinical Infectious Diseases (2021) Vol. 73, Iss. 3, pp. e699-e709
Open Access | Times Cited: 276

Showing 26-50 of 276 citing articles:

Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?
Ali Hamady, JinJu Lee, Zuzanna Loboda
Infection (2021) Vol. 50, Iss. 1, pp. 11-25
Open Access | Times Cited: 68
Estimated Half-Life of SARS-CoV-2 Anti-Spike Antibodies More Than Double the Half-Life of Anti-nucleocapsid Antibodies in Healthcare Workers
Jan Van Elslande, Lien Gruwier, Lode Godderis, et al.
Clinical Infectious Diseases (2021) Vol. 73, Iss. 12, pp. 2366-2368
Open Access | Times Cited: 67
Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection
Julien Favresse, Christine Eucher, Marc Elsen, et al.
Microorganisms (2021) Vol. 9, Iss. 3, pp. 556-556
Open Access | Times Cited: 59
Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications
Mars Stone, Eduard Grebe, Hasan Sulaeman, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 3, pp. 672-683
Open Access | Times Cited: 58
Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study
Christian Erikstrup, Anna Laksafoss, Josephine Gladov, et al.
The Lancet Regional Health - Europe (2022) Vol. 21, pp. 100479-100479
Open Access | Times Cited: 50
COVID‐19 and plasma cells: Is there long‐lived protection?*
Doan C. Nguyen, Pedro A. Lamothe, Matthew C. Woodruff, et al.
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 40-63
Open Access | Times Cited: 41
Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)
Mohammad Talaei, Sian Faustini, Hayley Holt, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 39
Antibodies to SARS-CoV-2 are associated with protection against reinfection
Sheila Lumley, Denise O’Donnell, Nicole Stoesser, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 55
An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status
Sheila Lumley, Gillian Rodger, Bede Constantinides, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 54
Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection
Catharina Gerhards, Margot Thiaucourt, Maximilian Kittel, et al.
International Journal of Infectious Diseases (2021) Vol. 107, pp. 221-227
Open Access | Times Cited: 52
Time of Day of Vaccination Affects SARS-CoV-2 Antibody Responses in an Observational Study of Health Care Workers
Wei Wang, Peter Balfe, David W. Eyre, et al.
Journal of Biological Rhythms (2021) Vol. 37, Iss. 1, pp. 124-129
Open Access | Times Cited: 51
High Prevalence of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (Anti–SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey
Antoine Nkuba-Ndaye, Sheila Makiala‐Mandanda, Emilande Guichet, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 5, pp. 882-890
Open Access | Times Cited: 48
Long-term specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients
Jira Chansaenroj, Ritthideach Yorsaeng, Nawarat Posuwan, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 48
The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery
Maddalena Peghin, Maria De Martino, Martina Fabris, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 11
Open Access | Times Cited: 48
Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests.
Isabel Montesinos, Hafid Dahma, Fleur Wolff, et al.
Journal of Clinical Virology (2021) Vol. 144, pp. 104988-104988
Open Access | Times Cited: 43
Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain
Mario Poljak, Anja Oštrbenk Valenčak, Tina Štamol, et al.
Journal of Clinical Virology (2021) Vol. 137, pp. 104784-104784
Open Access | Times Cited: 40
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
Adriana Tomić, Donal Skelly, Ane Ogbe, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 30
Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil
Carlos A. Prete, Lewis Buss, Renata Buccheri, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 29
Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India
T. S. Selvavinayagam, Anavarathan Somasundaram, Jerard Maria Selvam, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Mechanistic models of humoral kinetics following COVID-19 vaccination
Daniel Stocks, Amy Thomas, Adam Finn, et al.
Journal of The Royal Society Interface (2025) Vol. 22, Iss. 222
Open Access
Association between SARS-CoV-2 infection and anti-apolipoprotein A-1 antibody in children
Nicolas Vuilleumier, Sabrina Pagano, Elsa Lorthe, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters
Edwards Pradenas, Víctor Urrea, Sílvia Marfil, et al.
Research Square (Research Square) (2025)
Closed Access
Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab
Chiara Cattaneo, Valeria Cancelli, Luisa Imberti, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 9
Open Access | Times Cited: 38
Duration of SARS-CoV-2 sero-positivity in a large longitudinal sero-surveillance cohort: the COVID-19 Community Research Partnership
David M. Herrington, John W. Sanders, Thomas F. Wierzba, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 37
Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel
Vivian Glück, Sonja Grobecker, Josef Köstler, et al.
Infection (2021) Vol. 50, Iss. 2, pp. 439-446
Open Access | Times Cited: 36

Scroll to top